Hi all,
I welcome all the new shareholders I see on the list. Well done, you have come in,on the last QTR. So far it's been an outstanding scientific game. PAA science people have done the yards with Lymphoma B in dogs and have come up Trump's.
Even the other day I sent some Bayesian data to a fellow peer for evaluation. That person came back to me and said I have bought some PAA shares. Did that person work out the mathematical formula No ( I am still waiting) , "but the Science is very good"
they said.
No point in telling me the Science is good. I know it's excellent.
But, I could bore you with my maths on the subject. I have been studying RM's old data and combining it with new data. So far we are on track . I am awaiting as said a peer to analyse my data before I give it to the HC die hards.
But, I do have something of great importance to share. Now some of us know I have been beating the drum to include two anti cancer drugs to the armature of MPL in the Phase 3 study.
Those being Gemcitabine and or Cisplatin. Both FDA approved.
The synergy of these drugs combined with MPL would be to my knowledge sensational.
The problem is we have a non toxic drug mixed with a toxic drug so we have a chemotherapy issue v MPL and Prednisolone a non toxic compound.
The question is the morbidity on the dog.
Our previous CSO did question what do the dogs think of live expectations V happiness in life . Obviously, one has to think very hard to provide an answer.
MPL V Dog happiness ( life unchanged or better) 75% all dogs (my unreviewed calculations)
But enough canine philosophy!
Recist 1. You will have seen we are grading one of our trial parameters on this. It's a complicated medical algorithm whereby tumour sizes are measured, some biomarkers are , X rays, CT scans, lymph nodes sizes etc etc.
Where do we stand against our toxic chemotherapy competitors. So far from what I can analyse.
Gemcitabine 24%
Cisplatin 34.8%
MPL/S 33.3%
So just to clarify FDA granted approval to a 24% candidate.
Ok that's another episode of the Science.
So far over the last 2 months I have increased my holdings over PAA & PAAO approximately 14%.
My previous posts have elicited this outcome, as in where we are today. I am a month behind, no one including PAA has a crystal ball or a magic wand for fulfilling time frames.
- Forums
- ASX - By Stock
- PAA
- Ann: Update on PharmAust Canine Cancer Trials
Ann: Update on PharmAust Canine Cancer Trials, page-43
-
- There are more pages in this discussion • 174 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add PAA (ASX) to my watchlist
(20min delay)
|
|||||
Last
17.3¢ |
Change
-0.008(4.17%) |
Mkt cap ! $83.90M |
Open | High | Low | Value | Volume |
18.0¢ | 18.0¢ | 17.3¢ | $59.77K | 338.7K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
13 | 376984 | 17.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
17.5¢ | 25091 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
12 | 366984 | 0.170 |
7 | 256513 | 0.165 |
9 | 399304 | 0.160 |
6 | 336734 | 0.155 |
8 | 227993 | 0.150 |
Price($) | Vol. | No. |
---|---|---|
0.180 | 252275 | 4 |
0.185 | 367471 | 6 |
0.190 | 820111 | 8 |
0.195 | 593409 | 10 |
0.200 | 302726 | 11 |
Last trade - 15.42pm 13/09/2024 (20 minute delay) ? |
Featured News
PAA (ASX) Chart |
The Watchlist
LPM
LITHIUM PLUS MINERALS LTD.
Simon Kidston, Non--Executive Director
Simon Kidston
Non--Executive Director
SPONSORED BY The Market Online